Intuitive Surgical, Inc. $ISRG Shares Sold by Generate Investment Management Ltd

Key Points

• Generate Investment Management Ltd. cut its Intuitive Surgical stake by 93.3% in the third quarter, selling 30,000 shares and retaining 2,154 shares valued at approximately $876,000. Institutional investors collectively own 83.64% of ISRG.
• Analyst sentiment remains broadly positive: ISRG has a consensus “Moderate Buy” rating and an average price target of $498.83, despite some recent downgrades and target reductions.
• Intuitive Surgical reported stronger-than-expected quarterly results, with EPS of $2.80 versus the $2.48 consensus and revenue of $2.89 billion, up 18.4% year over year. Shares recently traded at $415.85, down 1.5%.

Generate Investment Management Ltd trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 93.3% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 2,154 shares of the medical equipment provider's stock after selling 30,000 shares during the quarter. Generate Investment Management Ltd's holdings in Intuitive Surgical were worth $876,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in ISRG. Bank of New York Mellon Corp bought a new position in shares of Intuitive Surgical during the second quarter worth about $1,335,753,000. J. Stern & Co. LLP increased its holdings in shares of Intuitive Surgical by 18,504.6% in the 4th quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider's stock worth $1,204,788,000 after acquiring an additional 2,115,814 shares during the period. Arrowstreet Capital Limited Partnership lifted its position in Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider's stock valued at $970,635,000 after purchasing an additional 1,027,475 shares during the last quarter. Invesco Ltd. lifted its position in Intuitive Surgical by 17.4% in the 4th quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider's stock valued at $2,338,350,000 after purchasing an additional 611,268 shares during the last quarter. Finally, Capitolis Liquid Global Markets LLC boosted its stake in Intuitive Surgical by 1,070.2% during the 4th quarter. Capitolis Liquid Global Markets LLC now owns 503,171 shares of the medical equipment provider's stock valued at $284,976,000 after purchasing an additional 460,171 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

ISRG has been the subject of several recent analyst reports. Barclays upgraded shares of Intuitive Surgical to a "strong-buy" rating in a research report on Wednesday, October 7th. Sanford C. Bernstein reaffirmed an "outperform" rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Leerink Partners cut their price target on Intuitive Surgical from $573.00 to $454.00 and set an "outperform" rating on the stock in a report on Friday, July 17th. HSBC downgraded Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 price objective for the company. in a research report on Thursday, July 30th. Finally, Wall Street Zen lowered Intuitive Surgical from a "buy" rating to a "hold" rating in a report on Sunday, September 20th. One analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $498.83.

Intuitive Surgical Trading Down 1.5%

ISRG stock traded down $6.21 during trading on Wednesday, hitting $415.85. The company had a trading volume of 639,907 shares, compared to its average volume of 2,403,488. The firm has a market capitalization of $146.91 billion, a price-to-earnings ratio of 47.69, a P/E/G ratio of 3.23 and a beta of 1.46. The business has a 50 day moving average of $388.49 and a 200 day moving average of $410.14. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.48 by $0.32. The firm had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. Intuitive Surgical's revenue was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.81 EPS. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 1,089 shares of the business's stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $374.44, for a total transaction of $407,765.16. Following the sale, the vice president directly owned 1,026 shares in the company, valued at approximately $384,175.44. The trade was a 51.49% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the company's stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the completion of the sale, the executive vice president directly owned 5,320 shares of the company's stock, valued at approximately $2,016,280. This represents a 6.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 12,370 shares of company stock worth $4,891,989 in the last three months. Insiders own 0.60% of the company's stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: UBS reiterated its Buy rating and maintained a $500 price target, citing Intuitive Surgical’s long-term robotic-surgery growth runway. Intuitive Surgical: Buy Rating Reiterated on Long-Term Robotic Growth Runway
• Positive Sentiment: Zacks upgraded ISRG to Rank #2, or Buy, reflecting improving expectations for the company’s earnings outlook. Intuitive Surgical Upgraded to Buy
• Positive Sentiment: Intuitive Surgical is seeking FDA clearance for a next-generation robotic endoscope aimed at gastrointestinal care. Success could expand the company beyond its core surgical market and create a new growth opportunity. ISRG Is Expanding Beyond Surgery
• Positive Sentiment: Erste Group Bank modestly raised its EPS forecasts to $8.94 for fiscal 2026 and $10.09 for fiscal 2027, both above its previous estimates and the current full-year consensus of $8.87.
• Positive Sentiment: Leerink Partners maintained its Buy rating, adding to the constructive analyst commentary surrounding the stock. Leerink Partners Keeps Their Buy Rating

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company's products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.